Liberate the Breast Cancer Genes

BCA is a plaintiff in a lawsuit filed on May 12, challenging Myriad Genetics' patents on BRCA1 and BRCA2, the “breast cancer genes.”

Read our press release to learn more about the case and why BCA joined it.

BCA is the only breast cancer organization involved in the suit because we are the watchdogs of the breast cancer movement and we don't take money from companies that profit from or contribute to cancer.

Your support makes this important work possible!